ID   FRIH_HUMAN              Reviewed;         183 AA.
AC   P02794; B3KNR5; Q3KRA8; Q3SWW1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-JUL-2015, entry version 187.
DE   RecName: Full=Ferritin heavy chain;
DE            Short=Ferritin H subunit;
DE            EC=1.16.3.1;
DE   AltName: Full=Cell proliferation-inducing gene 15 protein;
DE   Contains:
DE     RecName: Full=Ferritin heavy chain, N-terminally processed;
GN   Name=FTH1; Synonyms=FTH, FTHL6; ORFNames=OK/SW-cl.84, PIG15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hepatocyte;
RX   PubMed=6323167;
RA   Costanzo F., Santoro C., Colantuoni V., Bensi G., Raugei G.,
RA   Romano V., Cortese R.;
RT   "Cloning and sequencing of a full length cDNA coding for a human
RT   apoferritin H chain: evidence for a multigene family.";
RL   EMBO J. 3:23-27(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3840162;
RA   Boyd D., Vecoli C., Belcher D.M., Jain S.K., Drysdale J.W.;
RT   "Structural and functional relationships of human ferritin H and L
RT   chains deduced from cDNA clones.";
RL   J. Biol. Chem. 260:11755-11761(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3023856;
RA   Chou C.-C., Gatti R.A., Fuller M.L., Concannon P., Wong A., Chada S.,
RA   Davis R.C., Salser W.A.;
RT   "Structure and expression of ferritin genes in a human promyelocytic
RT   cell line that differentiates in vitro.";
RL   Mol. Cell. Biol. 6:566-573(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3003694; DOI=10.1093/nar/14.2.721;
RA   Costanzo F., Colombo M., Staempfli S., Santoro C., Marone M.,
RA   Frank R., Delius H., Cortese R.;
RT   "Structure of gene and pseudogenes of human apoferritin H.";
RL   Nucleic Acids Res. 14:721-736(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3020541; DOI=10.1073/pnas.83.19.7226;
RA   Hentze M.W., Keim S., Papadopoulos P., O'Brien S., Modi W.,
RA   Drysdale J.W., Leonard W.J., Harford J.B., Klausner R.D.;
RT   "Cloning, characterization, expression, and chromosomal localization
RT   of a human ferritin heavy-chain gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7226-7230(1986).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7916709; DOI=10.1016/0378-1119(93)90380-L;
RA   Dhar M., Chauthaiwale V.M., Joshi J.G.;
RT   "Sequence of a cDNA encoding the ferritin H-chain from an 11-week-old
RT   human fetal brain.";
RL   Gene 126:275-278(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Chauthaiwale V.M., Dhar M., McLachlan D.R., Joshi J.G.;
RT   "Cloning of a novel full length cDNA for ferritin heavy chain from
RT   normal adult human and Alzheimer's brain.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Franco A.V., Gray C.P., Myers K., Hersey P.;
RT   "Detection of ferritin heavy chain by SEREX: a multifunctional
RT   molecule in malignant tumour cells.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a human cell proliferation gene 15.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Cervix, Colon, Lung, Ovary, Prostate, and
RC   Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 128-183.
RX   PubMed=6589621; DOI=10.1073/pnas.81.15.4751;
RA   Boyd D., Jain S.K., Crampton J., Barrett K.J., Drysdale J.;
RT   "Isolation and characterization of a cDNA clone for human ferritin
RT   heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4751-4755(1984).
RN   [16]
RP   INVOLVEMENT IN HFE5, AND TISSUE SPECIFICITY.
RX   PubMed=11389486; DOI=10.1086/321261;
RA   Kato J., Fujikawa K., Kanda M., Fukuda N., Sasaki K., Takayama T.,
RA   Kobune M., Takada K., Takimoto R., Hamada H., Ikeda T., Niitsu Y.;
RT   "A mutation, in the iron-responsive element of H ferritin mRNA,
RT   causing autosomal dominant iron overload.";
RL   Am. J. Hum. Genet. 69:191-197(2001).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179 AND SER-183, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=1992356; DOI=10.1038/349541a0;
RA   Lawson D.M., Artymiuk P.J., Yewdall S.J., Smith J.M.A.,
RA   Livingstone J.C., Treffry A., Luzzago A., Levi S., Arosio P.,
RA   Cesarini G., Thomas C.D., Shaw W.V., Harrison P.M.;
RT   "Solving the structure of human H ferritin by genetically engineering
RT   intermolecular crystal contacts.";
RL   Nature 349:541-544(1991).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   PubMed=9159481; DOI=10.1006/jmbi.1997.0970;
RA   Hempstead P.D., Yewdall S.J., Fernie A.R., Lawson D.M., Artymiuk P.J.,
RA   Rice D.W., Ford G.C., Harrison P.M.;
RT   "Comparison of the three-dimensional structures of recombinant human H
RT   and horse L ferritins at high resolution.";
RL   J. Mol. Biol. 268:424-448(1997).
CC   -!- FUNCTION: Stores iron in a soluble, non-toxic, readily available
CC       form. Important for iron homeostasis. Has ferroxidase activity.
CC       Iron is taken up in the ferrous form and deposited as ferric
CC       hydroxides after oxidation. Also plays a role in delivery of iron
CC       to cells. Mediates iron uptake in capsule cells of the developing
CC       kidney (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 4 Fe(2+) + 4 H(+) + O(2) = 4 Fe(3+) + 2 H(2)O.
CC   -!- SUBUNIT: Oligomer of 24 subunits. There are two types of subunits:
CC       L (light) chain and H (heavy) chain. The major chain can be light
CC       or heavy, depending on the species and tissue type. In the human
CC       liver, the heavy chain is predominant. The functional molecule
CC       forms a roughly spherical shell with a diameter of 12 nm and
CC       contains a central cavity into which the insoluble mineral iron
CC       core is deposited.
CC   -!- INTERACTION:
CC       Q9UER7:DAXX; NbExp=5; IntAct=EBI-713259, EBI-77321;
CC       P02792:FTL; NbExp=8; IntAct=EBI-713259, EBI-713279;
CC       Q2Q067:HBZ (xeno); NbExp=3; IntAct=EBI-713259, EBI-9675545;
CC       P04792:HSPB1; NbExp=2; IntAct=EBI-713259, EBI-352682;
CC       P61244:MAX; NbExp=2; IntAct=EBI-713259, EBI-751711;
CC   -!- TISSUE SPECIFICITY: Expressed in the liver.
CC       {ECO:0000269|PubMed:11389486}.
CC   -!- DISEASE: Hemochromatosis 5 (HFE5) [MIM:615517]: A disorder of iron
CC       metabolism characterized by iron overload. Excess iron is
CC       deposited in a variety of organs leading to their failure, and
CC       resulting in serious illnesses including cirrhosis, hepatomas,
CC       diabetes, cardiomyopathy, arthritis, and hypogonadotropic
CC       hypogonadism. Severe effects of the disease usually do not appear
CC       until after decades of progressive iron loading.
CC       {ECO:0000269|PubMed:11389486}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. In a
CC       Japanese family affected by HFE5, a single point mutation has been
CC       detected in the iron-responsive element (IRE) in the 5'-UTR of
CC       FTH1 mRNA. This mutation leads to an increased binding affinity
CC       for iron regulatory protein and thereby to the efficient
CC       suppression of mRNA translation.
CC   -!- SIMILARITY: Belongs to the ferritin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 ferritin-like diiron domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00085}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI05803.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ferritin entry;
CC       URL="http://en.wikipedia.org/wiki/Ferritin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00318; CAA25086.1; -; mRNA.
DR   EMBL; M11146; AAA52437.1; -; mRNA.
DR   EMBL; M12937; AAA35830.1; -; mRNA.
DR   EMBL; X03487; CAA27205.1; -; Genomic_DNA.
DR   EMBL; X03488; CAA27205.1; JOINED; Genomic_DNA.
DR   EMBL; M14212; AAA52438.1; -; Genomic_DNA.
DR   EMBL; M14211; AAA52438.1; JOINED; Genomic_DNA.
DR   EMBL; M97164; AAA35832.1; -; mRNA.
DR   EMBL; L20941; AAA35833.1; -; mRNA.
DR   EMBL; AF088851; AAF89523.1; -; mRNA.
DR   EMBL; AY258285; AAP82230.1; -; mRNA.
DR   EMBL; AB062402; BAB93489.1; -; mRNA.
DR   EMBL; AK054816; BAG51427.1; -; mRNA.
DR   EMBL; DQ496108; ABF47097.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW73989.1; -; Genomic_DNA.
DR   EMBL; BC000857; AAH00857.1; -; mRNA.
DR   EMBL; BC001399; AAH01399.1; -; mRNA.
DR   EMBL; BC011359; AAH11359.1; -; mRNA.
DR   EMBL; BC013724; AAH13724.1; -; mRNA.
DR   EMBL; BC015156; AAH15156.1; -; mRNA.
DR   EMBL; BC016009; AAH16009.1; -; mRNA.
DR   EMBL; BC016857; AAH16857.1; -; mRNA.
DR   EMBL; BC063514; AAH63514.1; -; mRNA.
DR   EMBL; BC066961; AAH66961.1; -; mRNA.
DR   EMBL; BC073750; AAH73750.1; -; mRNA.
DR   EMBL; BC104643; AAI04644.1; -; mRNA.
DR   EMBL; BC105802; AAI05803.1; ALT_INIT; mRNA.
DR   EMBL; M15383; AAA52479.1; -; mRNA.
DR   CCDS; CCDS41655.1; -.
DR   PIR; A23517; FRHUH.
DR   RefSeq; NP_002023.2; NM_002032.2.
DR   UniGene; Hs.524910; -.
DR   UniGene; Hs.645560; -.
DR   PDB; 1FHA; X-ray; 2.40 A; A=1-183.
DR   PDB; 2CEI; X-ray; 1.80 A; A=2-183.
DR   PDB; 2CHI; X-ray; 1.60 A; A=2-183.
DR   PDB; 2CIH; X-ray; 1.50 A; A=2-183.
DR   PDB; 2CLU; X-ray; 2.10 A; A=2-183.
DR   PDB; 2CN6; X-ray; 2.20 A; A=2-183.
DR   PDB; 2CN7; X-ray; 1.75 A; A=2-183.
DR   PDB; 2FHA; X-ray; 1.90 A; A=1-183.
DR   PDB; 2IU2; X-ray; 1.80 A; A=2-183.
DR   PDB; 2Z6M; X-ray; 2.72 A; A/B/C/D/E/F/G/H/I/J/K/L=2-177.
DR   PDB; 3AJO; X-ray; 1.52 A; A=2-183.
DR   PDB; 3AJP; X-ray; 1.90 A; A=2-183.
DR   PDB; 3AJQ; X-ray; 1.58 A; A=2-183.
DR   PDB; 3ERZ; X-ray; 3.06 A; A/B/C/D/E/F/G/H/I/J/K/L=1-183.
DR   PDB; 3ES3; X-ray; 2.79 A; A=1-183.
DR   PDB; 4DYX; X-ray; 1.85 A; A=6-177.
DR   PDB; 4DYY; X-ray; 1.90 A; A=6-177.
DR   PDB; 4DYZ; X-ray; 2.30 A; A=6-177.
DR   PDB; 4DZ0; X-ray; 2.50 A; A=6-177.
DR   PDBsum; 1FHA; -.
DR   PDBsum; 2CEI; -.
DR   PDBsum; 2CHI; -.
DR   PDBsum; 2CIH; -.
DR   PDBsum; 2CLU; -.
DR   PDBsum; 2CN6; -.
DR   PDBsum; 2CN7; -.
DR   PDBsum; 2FHA; -.
DR   PDBsum; 2IU2; -.
DR   PDBsum; 2Z6M; -.
DR   PDBsum; 3AJO; -.
DR   PDBsum; 3AJP; -.
DR   PDBsum; 3AJQ; -.
DR   PDBsum; 3ERZ; -.
DR   PDBsum; 3ES3; -.
DR   PDBsum; 4DYX; -.
DR   PDBsum; 4DYY; -.
DR   PDBsum; 4DYZ; -.
DR   PDBsum; 4DZ0; -.
DR   ProteinModelPortal; P02794; -.
DR   SMR; P02794; 6-177.
DR   BioGrid; 108773; 94.
DR   DIP; DIP-38301N; -.
DR   IntAct; P02794; 32.
DR   MINT; MINT-4822446; -.
DR   STRING; 9606.ENSP00000273550; -.
DR   DrugBank; DB00893; Iron Dextran.
DR   PhosphoSite; P02794; -.
DR   BioMuta; FTH1; -.
DR   DMDM; 120516; -.
DR   UCD-2DPAGE; P02794; -.
DR   MaxQB; P02794; -.
DR   PaxDb; P02794; -.
DR   PRIDE; P02794; -.
DR   DNASU; 2495; -.
DR   Ensembl; ENST00000273550; ENSP00000273550; ENSG00000167996.
DR   Ensembl; ENST00000620041; ENSP00000484477; ENSG00000167996.
DR   GeneID; 2495; -.
DR   KEGG; hsa:2495; -.
DR   UCSC; uc001nsu.3; human.
DR   CTD; 2495; -.
DR   GeneCards; GC11M061731; -.
DR   H-InvDB; HIX0128677; -.
DR   H-InvDB; HIX0200367; -.
DR   HGNC; HGNC:3976; FTH1.
DR   HPA; CAB008623; -.
DR   HPA; HPA043650; -.
DR   MIM; 134770; gene.
DR   MIM; 615517; phenotype.
DR   neXtProt; NX_P02794; -.
DR   Orphanet; 247790; FTH1-related iron overload.
DR   PharmGKB; PA28392; -.
DR   eggNOG; COG1528; -.
DR   GeneTree; ENSGT00760000119129; -.
DR   HOVERGEN; HBG000410; -.
DR   InParanoid; P02794; -.
DR   KO; K00522; -.
DR   OMA; FANWFYV; -.
DR   PhylomeDB; P02794; -.
DR   TreeFam; TF313885; -.
DR   BRENDA; 1.16.3.1; 2681.
DR   Reactome; REACT_163699; Scavenging by Class A Receptors.
DR   Reactome; REACT_19400; Golgi Associated Vesicle Biogenesis.
DR   Reactome; REACT_25060; Iron uptake and transport.
DR   ChiTaRS; FTH1; human.
DR   EvolutionaryTrace; P02794; -.
DR   GeneWiki; FTH1; -.
DR   GenomeRNAi; 2495; -.
DR   NextBio; 9857; -.
DR   PRO; PR:P02794; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; P02794; -.
DR   CleanEx; HS_FTH1; -.
DR   ExpressionAtlas; P02794; baseline and differential.
DR   Genevisible; P02794; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0008043; C:intracellular ferritin complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008199; F:ferric iron binding; IEA:InterPro.
DR   GO; GO:0004322; F:ferroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005506; F:iron ion binding; TAS:ProtInc.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; ISS:UniProtKB.
DR   GO; GO:0006880; P:intracellular sequestering of iron ion; IDA:UniProtKB.
DR   GO; GO:0006826; P:iron ion transport; IEA:InterPro.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; IDA:UniProtKB.
DR   GO; GO:0006892; P:post-Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   Gene3D; 1.20.1260.10; -; 1.
DR   InterPro; IPR001519; Ferritin.
DR   InterPro; IPR009040; Ferritin-like_diiron.
DR   InterPro; IPR009078; Ferritin-like_SF.
DR   InterPro; IPR012347; Ferritin-rel.
DR   InterPro; IPR014034; Ferritin_CS.
DR   InterPro; IPR008331; Ferritin_DPS_dom.
DR   PANTHER; PTHR11431; PTHR11431; 1.
DR   Pfam; PF00210; Ferritin; 1.
DR   SUPFAM; SSF47240; SSF47240; 1.
DR   PROSITE; PS00540; FERRITIN_1; 1.
DR   PROSITE; PS00204; FERRITIN_2; 1.
DR   PROSITE; PS50905; FERRITIN_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Iron; Iron storage;
KW   Metal-binding; Oxidoreductase; Phosphoprotein; Reference proteome.
FT   CHAIN         1    183       Ferritin heavy chain.
FT                                /FTId=PRO_0000201048.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000269|PubMed:22814378}.
FT   CHAIN         2    183       Ferritin heavy chain, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000424472.
FT   DOMAIN       11    160       Ferritin-like diiron.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00085}.
FT   METAL        28     28       Iron 1.
FT   METAL        63     63       Iron 1.
FT   METAL        63     63       Iron 2.
FT   METAL        66     66       Iron 1.
FT   METAL       108    108       Iron 2.
FT   METAL       142    142       Iron 2.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000269|PubMed:22814378}.
FT   MOD_RES       2      2       N-acetylthreonine; in Ferritin heavy
FT                                chain, N-terminally processed.
FT                                {ECO:0000269|PubMed:22814378}.
FT   MOD_RES     179    179       Phosphoserine.
FT                                {ECO:0000269|PubMed:17081983,
FT                                ECO:0000269|PubMed:18318008,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000269|PubMed:18318008}.
FT   CONFLICT    176    183       LGDSDNES -> WETVIMKAKPRANFP (in Ref. 1;
FT                                CAA25086). {ECO:0000305}.
FT   HELIX        15     42       {ECO:0000244|PDB:2CIH}.
FT   TURN         45     47       {ECO:0000244|PDB:2CIH}.
FT   HELIX        50     77       {ECO:0000244|PDB:2CIH}.
FT   HELIX        97    124       {ECO:0000244|PDB:2CIH}.
FT   HELIX       128    137       {ECO:0000244|PDB:2CIH}.
FT   HELIX       139    159       {ECO:0000244|PDB:2CIH}.
FT   TURN        160    163       {ECO:0000244|PDB:2CIH}.
FT   HELIX       165    174       {ECO:0000244|PDB:2CIH}.
SQ   SEQUENCE   183 AA;  21226 MW;  FEF75640A29CCF56 CRC64;
     MTTASTSQVR QNYHQDSEAA INRQINLELY ASYVYLSMSY YFDRDDVALK NFAKYFLHQS
     HEEREHAEKL MKLQNQRGGR IFLQDIKKPD CDDWESGLNA MECALHLEKN VNQSLLELHK
     LATDKNDPHL CDFIETHYLN EQVKAIKELG DHVTNLRKMG APESGLAEYL FDKHTLGDSD
     NES
//
